Paper30100549
Renaming low risk conditions labelled as cancer.
Nickel B and 4 others. BMJ, 2018. Cited by 35 papers, by iCite.
Cite this record
ConductScience Library. Renaming low risk conditions labelled as cancer. Papers, record 30100549. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30100549
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Terminology as Topic | Major topic |
| Attitude to Health | |
| Humans | |
| Social Stigma |
Source PubMed
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39806624 | Impact of alternative diagnostic labels for melanoma in situ on management choices and psychological outcomes: protocol for an online randomised study. | BMJ Open | 2024 | https://conductscience.org/library/papers/39806624 | PubMed |
| 39420909 | Implementing active surveillance for low-risk thyroid carcinoma into clinical practice: collaborative recommendations for Latin America. | Arch Endocrinol Metab | 2024 | https://conductscience.org/library/papers/39420909 | PubMed |
| 39212985 | Cancer Care Terminology in African Languages. | JAMA Netw Open | 2024 | https://conductscience.org/library/papers/39212985 | PubMed |
| 39122400 | Impact of the diagnostic label for a low-risk prostate lesion: protocol for two online factorial randomised experiments. | BMJ Open | 2024 | https://conductscience.org/library/papers/39122400 | PubMed |
| 37838682 | Recruiting women with ductal carcinoma in situ to a randomised controlled trial: lessons from the LORIS study. | Trials | 2023 | https://conductscience.org/library/papers/37838682 | PubMed |
| 37478123 | Women's views about current and future management of Ductal Carcinoma in Situ (DCIS): A mixed-methods study. | PLoS One | 2023 | https://conductscience.org/library/papers/37478123 | PubMed |
| 37074481 | Should low-risk DCIS lose the cancer label? An evidence review. | Breast Cancer Res Treat | 2023 | https://conductscience.org/library/papers/37074481 | PubMed |
| 36889825 | Consequences of early thyroid ultrasound on subsequent tests, morbidity and costs: an explorative analysis of routine health data from German ambulatory care. | BMJ Open | 2023 | https://conductscience.org/library/papers/36889825 | PubMed |
| 36811453 | Low-risk prostate lesions: An evidence review to inform discussion on losing the "cancer" label. | Prostate | 2023 | https://conductscience.org/library/papers/36811453 | PubMed |
| 36568283 | Cancer overdiagnosis: a challenge in the era of screening. | J Natl Cancer Cent | 2022 | https://conductscience.org/library/papers/36568283 | PubMed |
| 35626380 | The Use of Digital Pathology and Artificial Intelligence in Histopathological Diagnostic Assessment of Prostate Cancer: A Survey of Prostate Cancer UK Supporters. | Diagnostics (Basel) | 2022 | https://conductscience.org/library/papers/35626380 | PubMed |
| 35099399 | Ethical Issues of Digital Twins for Personalized Health Care Service: Preliminary Mapping Study. | J Med Internet Res | 2022 | https://conductscience.org/library/papers/35099399 | PubMed |
| 35007335 | Do we need to rethink the diagnoses melanoma in situ and severely dysplastic naevus? | Br J Dermatol | 2022 | https://conductscience.org/library/papers/35007335 | PubMed |
| 33428025 | Overdiagnosis: one concept, three perspectives, and a model. | Eur J Epidemiol | 2021 | https://conductscience.org/library/papers/33428025 | PubMed |
| 32999857 | Screening for scoliosis - New recommendations, old dilemmas, no straight solutions. | World J Orthop | 2020 | https://conductscience.org/library/papers/32999857 | PubMed |
| 32690532 | Media coverage of calls to rename low-risk cancers: a content analysis. | BMJ Open | 2020 | https://conductscience.org/library/papers/32690532 | PubMed |
| 32313870 | The impact of the illness label 'gout' on illness and treatment perceptions in Māori (Indigenous New Zealanders). | BMC Rheumatol | 2020 | https://conductscience.org/library/papers/32313870 | PubMed |
| 30796581 | Expanding disease and undermining the ethos of medicine. | Eur J Epidemiol | 2019 | https://conductscience.org/library/papers/30796581 | PubMed |
| 30627960 | National consensus recommendations on patient-centered care for ductal carcinoma in situ. | Breast Cancer Res Treat | 2019 | https://conductscience.org/library/papers/30627960 | PubMed |
| 30361301 | The elusive diagnosis of cancer: testing times. | Br J Gen Pract | 2018 | https://conductscience.org/library/papers/30361301 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30100549
GET https://conductscience.org/api/papers/v1/30100549/authors